Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa
- 1 December 1986
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 54 (3) , 689-694
- https://doi.org/10.1128/iai.54.3.689-694.1986
Abstract
The interaction of complement with the following two strains of Pseudomonas aeruginosa was examined: 144M, a mucoid, serum-sensitive strain bearing short lipopolysaccharide O chains, and 144M-SR, a mucoid, serum-resistant strain bearing long lipopolysaccharide O chains isolated by repeated passage of 144M in increasing concentrations of pooled normal human serum (PNHS). While significant killing of 144M occurred in 5 to 40% PNHS, no killing of 144M-SR was observed. Both strains activated complement, especially 144M-SR which consumed 88.7, 96.4, and 100% of the available complement 3 (C3), C5, and C9, respectively, in 10% PNHS during a 60-min incubation at 37 degrees C. Although it activated more C3 than did 144M (54.9% consumption), 144M-SR bound only half as much C3 as 144M. Similarly, although 144M-SR activated more C9 than did 144M (50.0% consumption in 60 min), there was considerably less C9 attached to 144M-SR (2,990 molecules of C9 per bacterium) than to 144M (13,700 molecules per bacterium) after 60 min of incubation. Furthermore, only 162 molecules of the C9 bound to 144M-SR remained bound after treatment with 0.1% trypsin, while 5,692 molecules of the C9 bound to 144M remained bound under similar conditions. These results show that the serum resistance of 144M-SR does not represent a failure to activate complement efficiently, but instead reflects failure of the assembled terminal complement complex C5b-9 to insert stably into the outer membrane of this strain.This publication has 31 references indexed in Scilit:
- A quantitative method for assessing the third complement factor (C3) attached to the surface of opsonized Pseudomonas aeruginosa: Interrelationship between C3 fixation, phagocytosis and complement consumptionJournal of Immunological Methods, 1985
- C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.The Journal of Experimental Medicine, 1984
- Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coliMolecular Immunology, 1984
- The serum sensitivity, colonial morphology, serogroup specificity, and outer membrane protein of Pseudomonas aeruginosa strains isolated from several clinical sitesDiagnostic Microbiology and Infectious Disease, 1983
- Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membraneThe Journal of Experimental Medicine, 1982
- Serum-induced lysis ofPseudomonas aeruginosaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1982
- Synergy between Carbenicillin and an Aminoglycoside (Gentamicin or Tobramycin) against Pseudomonas aeruginosa Isolated from Patients with Endocarditis and Sensitivity of Isolates to Normal Human SerumThe Journal of Infectious Diseases, 1979
- Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.The Journal of Experimental Medicine, 1979
- Analyses of Lipopolysaccharides Extracted from Penicillin-Resistant, Serum-Sensitive Salmonella MutantsJournal of General Microbiology, 1967
- Release of lipopolysaccharide by EDTA treatment of E., coliBiochemical and Biophysical Research Communications, 1965